SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Dale Baker who wrote (9567)6/2/1998 4:39:00 PM
From: Joey Two-Cents  Respond to of 18691
 
<Imagine the financial fallout....at least for a while.>

The world would rush to the safety of the US $. Good for the US bad for everyone else.



To: Dale Baker who wrote (9567)6/2/1998 4:44:00 PM
From: Lazlo Pierce  Read Replies (1) | Respond to of 18691
 
This from briefing.com. I'll let everyone fill in their own punchline :-)
************
Zonagen Inc. (ZONA) 36 13/16 +1/16: company says Vasomax male erectile dysfunction treatment well tolerated in Phase III study, though drug caused nasal congestion in 8% of patients...

Dave



To: Dale Baker who wrote (9567)6/2/1998 5:48:00 PM
From: Kailash  Read Replies (1) | Respond to of 18691
 
Dale -

thanks for the AEOS info - looks promising, though the lawsuit doesn't necessarily mean much. What are your other favorite shorts at the moment?

Zitl is behaving itself again, as is CFON. After the split, AMZN might finally descend; it's held up very well so far. Zitel's cash crunch is ominous; a dilution at this point would hammer the stock, as would a convertible. If they can't get profitable contracts fast they might have to fold.

Kailash


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News